Seranova Bio Revenue and Competitors
Estimated Revenue & Valuation
- Seranova Bio's estimated annual revenue is currently $1.1M per year.
- Seranova Bio's estimated revenue per employee is $155,000
Employee Data
- Seranova Bio has 7 Employees.
- Seranova Bio grew their employee count by -30% last year.
Seranova Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Senior Director, Data Science and Machine Learning | Reveal Email/Phone |
3 | Senior Research Associate | Reveal Email/Phone |
4 | Research Associate | Reveal Email/Phone |
Seranova Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 1 | -80% | N/A | N/A |
#2 | $4.3M | 28 | 8% | N/A | N/A |
#3 | $9.8M | 66 | -11% | N/A | N/A |
#4 | $1.4M | 9 | 350% | N/A | N/A |
#5 | $16.6M | 107 | -23% | N/A | N/A |
#6 | $4.5M | 29 | -22% | N/A | N/A |
#7 | $1.7M | 11 | 57% | N/A | N/A |
#8 | $2.3M | 15 | -6% | N/A | N/A |
#9 | $0.3M | 4 | -43% | N/A | N/A |
#10 | $4M | 26 | 0% | N/A | N/A |
What Is Seranova Bio?
Seranova Bio is striving to establish a new paradigm for therapeutic target discovery. Our REAP platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients’ autoantibodies with higher throughput and fidelity than existing technologies. Our technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. Seranova Bio aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments to autoimmune disease, neurodegeneration, and cancer.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 7 | 0% | N/A |
#2 | $1.1M | 7 | 0% | N/A |
#3 | $0.5M | 7 | 17% | N/A |
#4 | $0.5M | 7 | -61% | N/A |
#5 | $1.1M | 7 | 0% | N/A |